Volume 28, Number 7—July 2022
Dispatch
SARS-CoV-2 Delta–Omicron Recombinant Viruses, United States
Table
GISAID accession no. | State | GISAID virus name | Collection date | Bolotie results |
---|---|---|---|---|
EPI_ISL_8720194 |
TN |
hCoV-19/USA/TN-CDC-ASC210559252/2021 |
2021 Dec 31 |
21J (Delta): 1-22032; 21K (Omicron): 22033-29903 |
EPI_ISL_9147438 |
NJ |
hCoV-19/USA/NJ-CDC-IBX952397337138/2022 |
2022 Jan 4 |
21J (Delta): 1-22032; 21K (Omicron): 22033-29903 |
EPI_ISL_8981712 |
PA |
hCoV-19/USA/PA-CDC-LC0473996/2022 |
2022 Jan 4 |
21J (Delta): 1-22032; 21K (Omicron): 22033-29903 |
EPI_ISL_8981824 |
PA |
hCoV-19/USA/PA-CDC-LC0474055/2022 |
2022 Jan 4 |
21J (Delta): 1-22032; 21K (Omicron): 22033-29903 |
EPI_ISL_8981459 |
PA |
hCoV-19/USA/PA-CDC-LC0474301/2022 |
2022 Jan 4 |
21J (Delta): 1-22032; 21K (Omicron): 22033-29903 |
EPI_ISL_9088187 |
MA |
hCoV-19/USA/MA-CDC-STM-HZEBR92XC/2022 |
2022 Jan 12 |
21J (Delta): 1-22032; 21K (Omicron): 22033-29903 |
EPI_ISL_9147935 |
NJ |
hCoV-19/USA/NJ-CDC-IBX640654818289/2022 |
2022 Jan 12 |
21J (Delta): 1-22032; 21K (Omicron): 22033-29903 |
EPI_ISL_10389336 |
NJ |
hCoV-19/USA/NJ-CDC-ASC210553977/2022 |
2022 Feb 12 |
21J (Delta): 1-22032; 21K (Omicron): 22033-29903 |
EPI_ISL_10389339 | NJ | hCoV-19/USA/NJ-CDC-ASC210553978/2022 | 2022 Feb 12 | 21J (Delta): 1-22032; 21K (Omicron): 22033-29903 |
*These 9 candidate recombinant viruses were identified by an exhaustive search of publicly available SARS-CoV-2 viral genomes with orf1ab:2855V,4176N,6248S and S:95I,142D,157-,346K,501Y mutations. hCoV-19/USA/PA-CDC-LC0474055/2022 and hCoV-19/USA/PA-CDC-LC0474301/2022 underwent resequencing at the Centers for Disease Control and Prevention. Bolotie (3) identified all 9 as recombinant genomes between Delta (clade 21J) and Omicron (clade 21K). Bolotie cannot determine the true breakpoint because of high sequence homology, but the same region is identified for all 9 sequences (nt position 22032 as referenced to GenBank accession no. NC_045512.2).
References
- National Center for Immunization and Respiratory Diseases (NCIRD) DoVD. Science brief: emerging SARS-CoV-2 variants [cited 2022 Feb 17]. https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scientific-brief-emerging-variants.html
- Lai MM, Baric RS, Makino S, Keck JG, Egbert J, Leibowitz JL, et al. Recombination between nonsegmented RNA genomes of murine coronaviruses. J Virol. 1985;56:449–56. DOIPubMedGoogle Scholar
- Varabyou A, Pockrandt C, Salzberg SL, Pertea M. Rapid detection of inter-clade recombination in SARS-CoV-2 with Bolotie. Genetics. 2021;218:iyab074.
- Li X, Giorgi EE, Marichannegowda MH, Foley B, Xiao C, Kong X-P, et al. Emergence of SARS-CoV-2 through recombination and strong purifying selection. Sci Adv. 2020;6:
eabb9153 . DOIPubMedGoogle Scholar - Sekizuka T, Itokawa K, Saito M, Shimatani M, Matsuyama S, Hasegawa H, et al. Genome recombination between Delta and Alpha variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Jpn J Infect Dis. 2022;
JJID.2021.844 ; Epub ahead of print. DOIPubMedGoogle Scholar - Escalera-Zamudio M, Sánchez HGC, Arredondo LJD, Gutiérrez BRE. Proposal to redesignate B.1.631 as recombinant lineage XB [cited 2022 Feb 18]. https://virological.org/t/re-proposal-to-redesignate-b-1-631-as-recombinant-lineage-xb/746
- Jackson B, Rambaut A, Pybus OG, Robertson DL, Connor T, Loman NJ, et al. Recombinant SARS-CoV-2 genomes involving lineage B.1.1.7 in the UK [cited 2022 Feb 18]. https://virological.org/t/recombinant-sars-cov-2-genomes-involving-lineage-b-1-1-7-in-the-uk/658.
- Liu L, Iketani S, Guo Y, Chan JF, Wang M, Liu L, et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature. 2022;602:676–81. DOIPubMedGoogle Scholar
- Chakraborty C, Bhattacharya M, Sharma AR. Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance. Curr Opin Pharmacol. 2022;62:64–73. DOIPubMedGoogle Scholar
- Kreier F. Deltacron: the story of the variant that wasn’t. Nature. 2022;602:19. DOIPubMedGoogle Scholar
- Aksamentov I, Roemer C, Hodcroft EB, Neher RA. Nextclade: clade assignment, mutation calling and quality control for viral genomes. J Open Source Softw. 2021;6:3773. DOIGoogle Scholar
- Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, Callender C, et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018;34:4121–3. DOIPubMedGoogle Scholar
Page created: May 04, 2022
Page updated: June 18, 2022
Page reviewed: June 18, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.